IRCT201305233930N26已完成2 期
Efficacy of aripiprazole versus risperidone on body mass index for treating schizophrenia, a randomized double blind controlled clinical trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 years 至 60 years（—）
- 性别
- All
入选标准
- •patients with schizophrenia aged between 16 to 65 years old.
- •Exclusion criteria: serious uncontrolled medical condition such as hypothyroidism; pregnancy.
排除标准
- 未提供
研究者
相似试验
招募中
3 期
Treating obsessive-compulsive disorder in patients with Bipolar disorderCondition 1: Bipolar disorder. Condition 2: Obsessive-Compulsive disorder.Obsessive-compulsive disorderBipolar disorderIRCT20200614047761N1Babol University of Medical Sciences60
招募中
3 期
Aripiprazle in ADHD and ODDIRCT20160530028182N5Sanandaj University of Medical Sciences60
已完成
2 期
The Comparison of Aripiprazole versus Risperidone in Attention Deficit Hyperactivity DisorderAttention Deficit Hyperactivity Disorder.Hyperkinetic disordersIRCT2013050413215N1Vice Chancellor for Research, Shahid Beheshti University of Medical Sciences40
已完成
3 期
Aripiprazole versus risperidone in the treatment of children and adolescents with tic disordersTic disorder.Tic disordersIRCT201301053930N17Vice chancellor for research, Shiraz University of Medical Sciences60
已完成
3 期
Aripiprazole versus risperidone for treatment of autismPervasive developmental disorders.Childhood autismIRCT201110233930N15Vice chancellor for research, Shiraz University of Medical Sciences50